vimarsana.com
Home
Live Updates
Chemours Announces Management Actions and Delay of Form 10-K
Chemours Announces Management Actions and Delay of Form 10-K
Chemours Announces Management Actions and Delay of Form 10-K; Provides Preliminary Unaudited 2023 Year-End Results
The Board of Directors of The Chemours Company has appointed Denise Dignam as the Interim Chief Executive Officer and Matt Abbott as the Interim Chief Financial Officer .
Ms. Dignam joined...
Related Keywords
United States ,
Delaware ,
American ,
Mark Newman ,
Matt Abbott ,
Camela Wisel ,
Denise Dignam ,
Dupont De Nemours Inc ,
Chemours Company ,
Specialized Solutions ,
Securities Exchange ,
Eidp Inc ,
Partner At Pricewaterhousecoopers ,
Audit Committee ,
Engineering Technology ,
Information Technology ,
Exchange Commission ,
Audit Committee Of The Board Directors ,
Linkedin ,
Corteva Inc ,
Interim Chief Executive Officer ,
Interim Chief Financial Officer ,
Titanium Technologies ,
Advanced Performance Materials ,
Vice President ,
Global Operations ,
Global Senior Business Director ,
North American Business Director ,
Diversified Technologies ,
Industrial Resins ,
Pont De Nemours ,
Global Supply Chain ,
Global Business Manager ,
Sulfur Products ,
Global Sales Manager ,
Clean Technologies ,
Senior Vice President ,
Chief Enterprise Transformation Officer ,
Enterprise Capital Projects ,
Cyber Security ,
Data Analytics ,
Chemour Vice President ,
Data Analytics Leader ,
Chief Accounting Officer ,
Chief Audit Executive ,
Dawn Farrell ,
Net Sales ,
Chief Executive Officer Mark Newman ,
Chief Financial Officer Jonathan Lock ,
Principal Accounting Officer Camela Wisel ,
Chemours Ethics Hotline ,
Annual Report ,
Preliminary Year End Results ,
Advanced Performance Material Materials ,
Glycolic Acid ,
Dupont De Nemours ,
Securities Act ,
Securities Exchange Act ,
Quarterly Report ,